Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...
Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback